Free Consultation

Office Locations

The Cochran Firm Legal Blog

With Office Locations Nationwide

Friday, July 3, 2009

FDA Recommends Smaller Doses of Acetaminophen Products

The Food and Drug Administration (FDA) has recently recommended that companies manufacturing painkillers containing acetaminophen as its primary ingredient alter the dosage recommendations on their labels. The FDA panel voted 21-16 in favor of this reduced dosage warning.

This new measure is primarily aimed at Tylenol products, which are the most commonly used painkillers containing acetaminophen. However, other brands which also use acetaminophen as their active ingredient, such as Excedrin, will be asked to comply as well.

The current recommended maximum dosage of over-the-counter acetaminophen is 4 grams, or 8 pills per day. The FDA is asking drug companies to lower this dosage to prevent potentially fatal overdoses.

When taken in excess, acetaminophen has been found to lead to potentially fatal liver damage. According to the FDA, acetaminophen is currently the leading cause of liver failure in the United States. Consumers should also avoid drinking alcohol when taking these products, as this combination can exacerbate the damage caused to your liver.

If you or a loved one has experienced liver failure due to chronic overuse of acetaminophen products, the defective product lawyers at The Cochran Firm can help you receive the compensation you deserve.

Please contact the experienced defective consumer product lawyers at The Cochran Firm today to schedule a consultation. We serve clients nationwide.

Labels:

posted by Benjamin A. Irwin at 10:45 AM

1.800.THE FIRM | 1.800.843.3476

The Cochran Firm handles Civil Litigation and Criminal Defense claims for clients throughout the United States of America. The information on this website does not constitute legal advice nor form an attorney-client relationship.Please contact The Cochran Firm today to schedule a free consultation.

Site Design, Development and Optimization by Page 1 Solutions | © - | Disclaimer